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Abstract
Type 2 diabetes mellitus (T2DM) is one of the most severe public health problems
in  the  world.  In  recent  years,  evidences  show  a  commonness  of  utilization  of
alternative medicines such as  phytomedicine for  the treatment of  T2DM. Phenolic
acids  are  the  most  common  compounds  in  non-flavonoid  group  of  phenolic
compounds and have been suggested to have a potential to lower the risk of T2DM.
Skeletal muscle is the major organ that contributes to the pathophysiology of T2DM.
Studies have shown that several phenolic acids (caffeic acid, chlorogenic acid, gallic
acid, salicylic acid, p-coumaric acid, ferulic acid, sinapic acid) have antidiabetic effects,
and  these  compounds  have  been  implicated  in  the  regulation  of  skeletal  muscle
glucose  metabolism,  especially  glucose  transport.  Glucose  transport  is  a  major
regulatory step for whole-body glucose disposal, and the glucose transport processes
are regulated mainly through two different systems: insulin-dependent and insulin-
independent mechanism. In this chapter, we reviewed recent experimental evidences
linking  phenolic  acids  to  glucose  metabolism  focusing  on  insulin-dependent  and
insulin-independent glucose transport systems and the upstream signaling events in
skeletal muscle.
Keywords: glucose metabolism, 5′AMP-activated protein kinase, insulin, glucose
transporter, phytomedicine, phytochemical
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1. Introduction
Diabetes is one of the most rapidly increasing chronic diseases in the world. According to the
International  Diabetes  Federation [1],  there are now 415 million adults  aged 20–79 with
diabetes worldwide, and there will be 642 million people living with the disease by 2040. Type
2 diabetes mellitus (T2DM) is the most common type of diabetes, which is due primarily to
lifestyle factors and genetics. Numerous lifestyle factors, including excessive caloric intake,
physical inactivity, cigarette smoking, and generous consumption of alcohol, are considered
to be  important  to  the  development  of  T2DM [2].  T2DM care  is  usually  managed by a
multidisciplinary healthcare approach, which includes a combination of dietary restriction,
exercise, hypoglycemic agents, and/or insulin. In present times, evidences show a common-
ness of utilization of alternative medicines for the treatment of T2DM.
A traditional herbal medicine, also called as phytomedicine, has been used since ancient time
in many regions in the world. Phytomedicine is a medicine mainly derived from whole leaves,
roots, stems, and plant extracts for promoting health and treating illness [3]. Plants produce
numerous diversity of chemicals known as secondary metabolites through evolved secondary
biochemical pathways. These secondary metabolites serve as defense compounds against
herbivores or infection and thereby enhance their ability to survive. These compounds are also
helpful for humans to protect themselves against diseases and are called phytochemical. Each
type of fruit or vegetable contain hundreds of phytochemical, and these phytochemicals exhibit
multiple beneficial effects in the treatment of T2DM [4].
Phenolic acids, which are part of the secondary metabolites, belong to the family of phenolic
compounds and are the most common compounds in non-flavonoid group. Phenolic acids
are synthesized from the shikimic acid pathway from L-phenylalanine or L-tyrosine [5].
These compounds exist predominantly as hydroxybenzoic acids, which include gallic acid,
salicylic acid, protocatechuic acid, vanillic acid, and gentisic acid and hydroxycinnamic
Figure 1. Chemical structures of benzoic acid and cinnamic acid derivatives.
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acids, which include p-coumaric acid, caffeic acid, ferulic acid, sinapic acid, and chlorogenic
acid (Figure 1). They are abundant in edible vegetable, fruits, and nuts and are the main
contributors to the total polyphenol intake [6]. Although the beneficial role of phenolic acids
in the lifestyle-related diseases is still controversial, reports have suggested the inverse rela-
tionship between high levels of phenolic acids intake and metabolic syndrome including
T2DM [7, 8].
Because skeletal muscle is responsible for approximately 80% of insulin-mediated glucose
utilization [9], it is considered that defects in insulin action on skeletal muscle are key con-
tributors to the pathophysiology of T2DM. Studies have shown that several phenolic acids
have antidiabetic effects [8], and these compounds have been implicated in the regulation of
skeletal muscle glucose metabolism, especially glucose transport, a rate-limiting step for
glucose utilization. However, the precise mechanism of how phenolic acids modulate glucose
transport has not been firmly established. In this chapter, we provide recent experimental
evidences linking phenolic acids to glucose transport and upstream signaling pathways in
skeletal muscle.
2. Glucose transport in skeletal muscle
2.1. Glucose transport
Glucose transport is a major regulatory step for whole-body glucose disposal that occurs by a
system of facilitated diffusion with glucose transporter (GLUT)-mediated process. GLUT is a
protein of ∼500 amino acids and is predicted to possess 12 transmembrane-spanning alpha
helices and a single N-linked oligosaccharide. GLUT1, 3, 4, 5, 8, 10, 11, and 12 exist in mam-
malian skeletal muscle tissue, and especially, GLUT4 is the predominant glucose transporter
isoform present in skeletal muscle. GLUT4 is present in intracellular vesicular pool in the basal
non-stimulated state, and the translocation of GLUT4 from an intracellular location to the
plasma membrane and T-tubules is a major determinant of acute regulation of glucose
transport [10] (Figure 2). These glucose transport processes are regulated mainly through two
different systems: insulin-dependent and insulin-independent mechanism.
2.2. Regulation of insulin-dependent glucose transport
Insulin is a peptide hormone produced by β cells of the pancreatic islets. Insulin consists of
two polypeptide chains, the A and B chains, linked together by disulfide bonds. It is first
synthesized as a single polypeptide called preproinsulin in pancreatic β-cells, and then it is
cleaved to form a smaller protein, proinsulin. The conversion of proinsulin to insulin occurs
through the combined action of the prohormone convertases [12].
The insulin receptor is a member of the ligand-activated receptor and tyrosine kinase family
of transmembrane-signaling proteins that consists of two extracellular α subunits and two
transmembrane β subunits connected by disulfide bridges [13]. Binding of insulin to the
extracellular domain of the insulin receptor α subunit triggers tyrosine phosphorylation of the
intracellular domain of the β subunit [14]. Following the autophosphorylation of the receptor,
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the insulin receptor phosphorylates insulin receptor substrate (IRS)-1 on tyrosine residues.
Tyrosine-phosphorylated IRS then binds to the Src homology 2 (SH2) domain-containing
adaptor protein p85, a regulatory subunit of phosphatidylinositol-3 kinase (PI3K), resulting in
activation of the catalytic p110 subunit of PI3K. This results in the generation of the critical
second messenger PI3,4,5-triphosphate, which in turn triggers the activation of Akt. Recently,
TBC1 domain family (TBC1D) member 1 (TBC1D1) and member 4 (TBC1D4) have been
suggested to act as downstream mediators of Akt. TBC1D1 and TBC1D4 contain Rab GTPase-
activating protein (GAP) domains that prevent GLUT4 translocation by inactivating Rab
proteins. TBC1D1 and TBC1D4 dissociate from GLUT4 vesicles in the phosphorylated state
and thereby facilitate GLUT4 translocation and glucose transport [15, 16] (Figure 2).
Figure 2. Molecular mechanism of stimulating insulin-dependent and insulin-independent glucose transport in skele-
tal muscle. This figure was adapted from Egawa et al. [11] with permission by the publisher. AMPK, 5′AMP-activated
protein kinase; CaMK, Ca2+/calmodulin-dependent protein kinase; CaMKK, Ca2+/calmodulin-dependent protein kinase
kinase; Cr, creatine; GLUT4, glucose transporter 4; IRS-1, insulin receptor substrate 1; LKB1, liver kinase B1; PCr, phos-
phocreatine; PKB, protein kinase B; PI3K, phosphatydilinositol-3 kinase; TBC1D1, TBC1 domain family member 1;
TBC1D4, TBC1 domain family member 4.
2.3. Regulation of insulin-independent glucose transport
A serine/threonine protein kinase, 5′AMP-activated protein kinase (AMPK), is critical for
insulin-independent glucose transport in the muscle through translocation of GLUT4. AMPK
comprises a catalytic α subunit and the regulatory subunits β and γ [17] in a total of 12 possible
heterotrimeric combinations of two α, two β, and three γ subunits [18]. In skeletal muscle, the
predominant heterotrimeric complexes include α1/β2/γ1, α2/β2/γ1, and α2/β2/γ3 [19]. The α
subunit has a catalytic domain that contains the activating phosphorylation site (Thr172) at the
N-terminus, an auto-inhibitory domain, and a conserved C-terminal domain that interacts
with β and γ subunits [20–24]. There are two distinct α isoforms (α1 and α2): α1 is expressed
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ubiquitously, whereas α2 is dominant in the skeletal muscle, heart, and liver [25]. The regula-
tory β subunit contains a C-terminal region that interacts with α and γ subunits and a central
region that binds glycogen [26]. The regulatory γ subunit contains binding sites of adenine
nucleotides (adenosine monophosphate (AMP), adenosine diphosphate (ADP), or adenosine
triphosphate (ATP)) [18].
AMPK typically works as a signaling intermediary in muscle cells by monitoring cellular
energy status, such as AMP/ATP ratio and creatine/creatine phosphate (PCr) ratio [17]. Binding
of AMP to the Bateman domains of the AMPK γ subunit leads the allosteric activation of AMPK
and phosphorylation of the Thr172 residue of the α subunit, which is crucial for maximal kinase
activity. The level of phosphorylation also depends on the balance of activities of upstream
kinases including liver kinase B1 (LKB1) and Ca2+/calmodulin-dependent protein kinase kinase
(CaMKK) and protein phosphatases [24, 27]. The LKB1 complex is constitutively active but is
not activated directly by AMP. The binding of AMP to AMPK induces a structural change that
assists phosphorylation of AMPK by the LKB1 complex [28, 29]. On the other hand, CaMKK
activates AMPK in response to increased intracellular Ca2+ levels independently of energy
status [30–32].
AMPK is also activated without energy depletion by 5-Aminoimidazole-4-carboxamide
ribonucleotide (AICAR), a pharmacological activator of AMPK. When taken up into skeletal
muscle, AICAR is converted by adenosine kinase to ZMP, a monophosphorylated derivative
that mimics the effects of AMP on AMPK [17]. AICAR-induced activation of AMPK leads to
insulin-independent stimulation of glucose transport in skeletal muscle [33, 34] accompanied
by GLUT4 translocation to the plasma membrane [35]. Moreover, AICAR-stimulated glucose
transport is abrogated completely in muscles from mice with muscle-specific expression of a
dominant-negative (kinase dead) form of AMPK [36], indicating that increased AMPK activity
is sufficient for the stimulation of glucose transport in skeletal muscle.
AICAR-stimulated glucose transport is not inhibited by a PI3K inhibitor wortmannin [33], and
the increase in glucose transport induced by the combination of maximal AICAR and maximal
insulin stimulation is partly additive [33]. Therefore, the underlying molecular signaling
mechanisms regulating insulin-dependent and insulin-independent glucose transport have
been considered to be distinct. In this regard, recent studies have revealed that AMPK
promotes GLUT4 translocation likely through TBC1D1 and TCB1D4 [37]. In short, insulin-
dependent and insulin-independent signaling of glucose transport systems seem to conver-
gence at TBC1D1 and TBC1D4 (Figure 2).
3. Phenolic acids and glucose transport
3.1. Caffeic acid
Caffeic acid (3,4-dihydroxycinnamic acid) is the most frequently studied phenolic acids in
diabetes research. A prospective investigation conducted in two cohorts of US women
demonstrated that there was an inverse association between urinary excretion level of caffeic
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acid and T2DM risk [38], indicating that dietary intake of caffeic acid may alleviate a
development of T2DM. Indeed, several studies have shown the hypoglycemic action of caffeic
acid. Intravenous injection of caffeic acid (0.5–5 mg/kg) into both streptozotocin (STZ)-
induced diabetic rats and rats with insulin resistance exhibited an acute (<30 min) effect of
lowering plasma glucose in a dose-dependent manner [39, 40]. Further, chronic (5–12 weeks)
dietary supplementation with caffeic acid (0.02–2%) lowered blood glucose level in diabetic
mice [41–43].
A previous work by us first demonstrated that incubation of isolated rat skeletal muscles with
caffeic acid (0.1–1 mM) acutely (<30 min) enhanced AMPKα Thr172 phosphorylation [44, 45]
(Figure 3). Phosphorylation of acetyl-CoA carboxylase (ACC) Ser79 exhibited parallel changes
to AMPK phosphorylation. ACC is a major substrate of AMPK in skeletal muscle, and
phosphorylation of ACC at Ser79 reflects the total AMPK activity [46–48]. Correspondingly,
caffeic acid (1 mM, 30 min) stimulated insulin-independent glucose transport in skeletal
muscle (Figure 4). Other researchers also have shown that caffeic acid enhanced insulin-
independent glucose transport in isolated adipocytes [39] and cultured muscle cells [40].
Therefore, the stimulatory effect of caffeic acid on insulin-independent glucose transport may
contribute to the hypoglycemic action, partly through AMPK-mediated mechanism.
Figure 3. The effect of caffeic acid on phosphorylation status of AMPKα Thr172 in skeletal muscle. (A) Isolated epitro-
chlearis muscles were incubated with caffeic acid at indicated concentration for 30 min. (B) Isolated epitrochlearis mus-
cles were incubated with caffeic acid (1 mM) at indicated time. Muscle lysates were then analyzed for phosphorylation
of AMPKα Thr172 (pAMPK) by western blot analysis. Fold increases are expressed relative to the level of muscles in the
non-stimulated group. Representative immunoblots are shown. Values are mean ± SE. *P < 0.05, **P < 0.01 vs. non-
stimulated group. This figure was adapted from Tsuda et al. [44] with permission by the publisher.
The finding that caffeic acid enhances phosphorylation status of AMPKα Thr172 indicates that
caffeic acid leads to covalent modification through upstream kinases. Since the binding of AMP
to AMPK facilitates the phosphorylation of AMPK by the LKB1 complex [28], LKB1 is
considered as a crucial AMPK kinase in response to energy depletion in skeletal muscle. When
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cellular ATP level is depleted, phosphate is transferred from PCr to ADP to reproduce ATP.
Decreased PCr level leads to an increase in free ADP and thereby causes AMP accumulation
through the reaction of adenylate kinase, and thus a reduction of PCr level indicates a cellular
energy depletion. In our previous work [44], we observed that incubation of rat skeletal
muscles with caffeic acid decreased PCr level, suggesting that LKB1 is a possible kinase to
enhance the caffeic acid-induced AMPKα Thr172 phosphorylation.
Figure 4. The effect of caffeic acid on insulin-independent glucose transport in rat skeletal muscles. Isolated epitro-
chlearis muscles were incubated in the absence (control) or presence of 1 mM caffeic acid for 30 min, and then glucose
transport activity was measured using the glucose analog 3-O-methylglucose. Values are mean ± SE. *P < 0.05 vs. con-
trol. This figure was adapted from Tsuda et al. [44] with permission by the publisher.
Exercise (muscle contraction) is a strong stimulator for insulin-independent glucose transport.
Due to the provision of energy for contracting muscle during exercise, AMP and ADP levels
are rapidly increased in an intensity-dependent manner while ATP levels decline slightly. Since
AMPK is a sensor of cellular energy status that is activated by AMP/ATP ratio, AMPK is
activated during exercise in an intensity-dependent manner [49–52]. Thus, exercise can
regulate insulin-independent glucose transport by a mechanism involving AMPK [33]. Recent
work by us showed an interesting finding that muscle contraction and caffeine, which is the
most widely consumed phytoactive substance in the world, synergistically stimulate insulin-
independent glucose transport and AMPK Thr172 phosphorylation in skeletal muscle [45]. This
result indicates the possibility that some phytochemicals enhance the maximal capacity of
contraction-induced AMPK activity in skeletal muscle. In the point of view, we evaluated the
effect of caffeic acid on contraction-stimulated AMPK activity in skeletal muscle. Maximal
activation of AMPK by contraction was induced by 10 min tetanic contraction according to the
protocol by Musi et al. [52]. AMPKα Thr172 phosphorylation was increased in response to caffeic
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acid (1 mM, 30 min) stimulation; however, caffeic acid had no effect on the contraction-
stimulated AMPKα Thr172 phosphorylation [45]. This finding suggests that caffeic acid has no
capacity for enhancing contraction-induced AMPK activity.
It seems that caffeic acid stimulates insulin-dependent glucose transport at insulin resistance
state in skeletal muscle. Insulin resistance is in which there are impaired biological and
physiological responses to insulin in the tissue, and skeletal muscle insulin resistance is a major
factor in the pathogenesis of T2DM. The underlying cellular mechanisms are yet unclear, but
tumor necrosis factor α (TNFα), which is a member of the TNF ligand superfamily and a
multifunctional cytokine, is implicated in the development of insulin resistance [53]. Activation
of the TNF receptor results in stimulation of nuclear factor-κB (NF-κB) signaling via inhibitor
κB kinase (IKK). IKK is the master regulator of NF-κB activation in response to inflammatory
stimuli, and the IKK/NF-κB pathway is considered to be a core mechanism that causes insulin
resistance in peripheral tissues including skeletal muscle [54, 55]. We demonstrated that,
during insulin-stimulated condition, caffeine-induced insulin resistance which includes
activation of IKK/NF-κB signaling and suppression of Akt Ser473 phosphorylation, which is
required for the full activation of Akt, and insulin-dependent glucose transport, were allevi-
ated by the treatment with caffeic acid in rat skeletal muscle [56]. Hence, caffeic acid may have
an ability to improve insulin resistance state that is induced by activation of IKK/NF-κB
signaling. Notably, caffeic acid does not stimulate insulin signaling pathway in normal state
because we have shown that incubation of isolated rat skeletal muscle with caffeic acid had no
effect on stimulating Akt Ser473 phosphorylation in the basal condition [44, 45].
3.2. Chlorogenic acid
Chlorogenic acid is the ester of caffeic acid and (−)-quinic acid and has been implicated in
reducing the risk of T2DM. In animal study, treatment of chlorogenic acid (250 mg/kg) acutely
(<30 min) lowered blood glucose concentration during glucose tolerance test in diabetic db/db
mice [57, 58]. Furthermore, repeated (2–12 weeks) treatment of chlorogenic acid (80–250
mg/kg/day) improved fasting blood glucose concentration, HOMA-IR index (fasting insulin
[μU/ml]×fasting glucose [mmol/l]/22.5), blood glucose concentration during glucose or insulin
tolerance test in db/db mice [58, 59], and high-fat diet-induced diabetic mice [60]. Intervention
with lower doses of chlorogenic acid (5 mg/kg/day) also improved the peak blood glucose
concentration during glucose tolerance test in Zucker (fa/fa) rats although fasting blood
glucose concentration did not change [61]. In human study, chlorogenic acid ingestion (1 g)
reduced blood glucose concentration during oral glucose tolerance test in overweight men [62].
Thus, the accumulated evidences strongly suggest that chlorogenic acid has a hypoglycemic
effect, but the cellular mechanism of action is not fully understood yet.
Stimulatory effect of chlorogenic acid on skeletal muscle glucose transport was firstly re-
ported by Prabhakar and Doble [63]. They revealed that incubation with chlorogenic acid
(25 μM) stimulated insulin-independent glucose transport within 3 h in differentiated L6
skeletal muscle cells. Subsequently, Ong et al. [57] demonstrated that incubation of isolated
skeletal muscle from db/db mice and L6 skeletal muscle cells with chlorogenic acid (1–10
mM) for 1–24 h enhanced insulin-independent glucose transport. They also showed that
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chlorogenic acid-stimulated glucose transport was inhibited by the pretreatment with com-
pound C, an AMPK inhibitor, but not wortmannin, a PI3K inhibitor. These findings suggest
that chlorogenic acid stimulates skeletal muscle glucose transport via insulin-independent
and AMPK-dependent mechanism.
The previous work by us investigated the acute effect of chlorogenic acid on AMPKα Thr172
phosphorylation status in rat skeletal muscle [44] and showed that incubation with chloro-
genic acid (<1 mM, <60 min) had no effect on AMPKα Thr172 phosphorylation in isolated rat
skeletal muscle. In contrast, Ong et al. [57] demonstrated that chlorogenic acid had an ability
to enhancing AMPK activity in L6 skeletal muscle cells in dose-dependent (1–10 mM) and
time-dependent (1–24 h) manners. These findings suggest that chlorogenic acid directly acts
skeletal muscle and stimulates AMPK, and that relatively higher concentration of chlorogenic
acid (>1 mM) and/or longer stimulation period (>60 min) is needed to stimulate skeletal muscle
AMPK.
Adiponectin is an adipokine that has been recognized as a key regulator of glucose metabolism.
Binding of adiponectin to adiponectin receptor AdipoR1 induces Ca2+ influx and leads to the
activation of CaMKK/AMPK signaling in skeletal muscle [64]. A study showed that AMPKα
Thr172 phosphorylation and ACC Ser79 phosphorylation were upregulated in response to
chronic (2 weeks) administration of chlorogenic acid (250 mg/kg/day) in skeletal muscle of db/
db mice [58]. In addition, the treatment also increased CaMKK expression in skeletal muscle.
More recently, Jin et al. [59] showed that treatment with chlorogenic acid (80 mg/kg/day) for
12 weeks increased AMPKα Thr172 phosphorylation as well as AdipoR1 expression in skeletal
muscle of db/db mice. Collectively, chronic treatment of chlorogenic acid may act as an
antidiabetic agent through stimulating adiponectin-AMPK signaling because AMPK induces
a variety of metabolic changes toward antidiabetic property: promoting glucose transport [33,
34, 36, 65], GLUT4 expression [66–68], fatty acid oxidation [49, 69, 70], mitochondrial biogen-
esis [71, 72], insulin sensitivity [73, 74], and fiber-type shift toward the slower and more
oxidative phenotype [75].
Notably, chlorogenic acid is hydrolyzed by intestinal microflora into various aromatic acid
metabolites including caffeic and quinic acids [76]. Additionally, it is reported that absorption
rate of caffeic acid in the small intestine of humans is 95% but chlorogenic acid is 33% [77].
These observations suggest that the health-promoting effects of chlorogenic acid might be
attributed to the actions of chlorogenic acid-derived caffeic acid. In this context, the stimulatory
effect of oral intake of chlorogenic acid as well as caffeic acid at physiological doses on AMPK
activation and AMPK-related metabolic events, including glucose transport in skeletal muscle,
must be confirmed.
3.3. Gallic acid
Gallic acid (3,4,5-trihydroxybenzoic acid) is known to have a variety of cellular functions
including beneficial effects on T2DM. Chronic treatment (4–16 weeks) with gallic acid (25–100
mg/kg/day) produced significant decrease in elevated fasting serum glucose level in STZ-
induced diabetic rats [78], in high-fat diet-induced diabetic mice [79], or in high-fat diet/STZ-
induced diabetic rats [80, 81]. Four weeks of treatment with gallic acid (10–30 mg/kg/day) in
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high-fructose diet-induced diabetic rats also ameliorates hyperglycemia and HOMA-IR index
and improved glucose clearance during oral glucose tolerance test [82].
A study reported that treatment with gallic acid (10 μM) for 30 min induces GLUT4 translo-
cation and insulin-independent glucose transport in 3T3-L1 adipocytes [83]. We found that a
water-soluble Pu-erh tea extract which contained 9.11% gallic acid stimulated Akt Ser473
phosphorylation in a dose- and time-dependent manner with a concomitant increase in
insulin-independent glucose transport in isolated rat skeletal muscle [84]. By contract, the Pu-
erh tea extract did not change the phosphorylation status of AMPKα Thr172. Correspondingly,
incubation of isolated rat skeletal muscle with gallic acid (820 μM) for 30 min robustly
stimulated Akt Ser473 phosphorylation without affecting AMPK phosphorylation [84]
(Figure 5). These findings indicate that gallic acid stimulates glucose transport via enhancing
insulin signaling transduction in the absence of insulin and raise the possibility that gallic acid
can be an insulin-mimetic agent.
Figure 5. The effect of gallic acid (GA) on phosphorylation status of Akt Ser473 and AMPKα Thr172 in skeletal muscle.
Isolated epitrochlearis muscles were incubated in the absence (Basal) or presence of epigallocatechin gallate (EGCG)
(2.2 μM), caffeine (150 μM), Pu-erh tea hot-water extract (PTE) (1.5 mg/mL), GA (820 μM), or insulin (1 μM) for 30 min.
The concentrations of GA, caffeine, and EGCG were adjusted to the concentration of each constituent to the level corre-
sponding to 1.5 mg/mL of PTE. Muscle lysates were then analyzed for phosphorylation of Akt Ser473 (pAkt) and
AMPKα Thr172 (pAMPK) by western blot analysis. Representative immunoblots are shown. This figure was adapted
from Ma et al. with permission by the publisher.
3.4. Salicylic acid
Salicylic acid (salicylate or 2-hydroxybenzoic acid) is one of the oldest drugs in clinical practice.
Salicylate has been used for treating pain, fever, and inflammation, but recent evidences have
accumulated the effectiveness of treating T2DM. Over 100 years ago, Ebstein [85] and Wil-
liamson [86] showed that high doses of sodium salicylate (5–7.5 g/day) reduced glucosuria in
diabetic patients. After that, additional trials have been reported similar effects that the
treatment of sodium salicylate improved glucose homeostasis [87–94]. A recent meta-analysis
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of salicylates, including sodium salicylate, aspirin (acetylsalicylate), and salsalate (2-[2-
hydroxybenzoyl]oxybenzoic acid), for T2DM showed that any doses of salicylates reduce
glycated hemoglobin (HbA1c) level and that high doses of sodium salicylate (>3000 mg/day)
improve fasting plasma glucose level [95].
The mechanism of antidiabetic action of salicylate might be attributed to the stimulation of
both insulin-dependent and insulin-independent glucose transport. Kim et al. [96] demon-
strated that infusion of lipid into tail vain of rats for 5 h impaired insulin-dependent glucose
transport in skeletal muscle, whereas the impairment was attenuated by concomitant infusion
of sodium salicylate (7 mg/kg/h). In that situation, the decreases in insulin-dependent glucose
transport in skeletal muscle were associated with the reduction of tyrosine phosphorylation
of IRS-1 and PI3K activity [96]. Salicylate is a known inhibitor of IKK/NF-κB signaling. Kim et
al. [96] also revealed that the defects of insulin-dependent glucose transport with lipid infusion
were not induced in IKK-β knockout mice. Overall, these results indicate that salicylate may
protect the defects of fat-induced insulin resistance in skeletal muscle by preserving insulin
signaling transduction via the inhibition of IKK/NF-κB signaling.
Recent work by us first showed that the treatment of sodium salicylate (5 mM, 30 min)
stimulated insulin-independent glucose transport in rat-isolated skeletal muscles [97]. The
stimulation of insulin-independent glucose transport by sodium salicylate may be explained
by the activation of AMPK. A study found that sodium salicylate (>1 mM) activates AMPK in
human embryonic kidney cells directly by binding to AMPK (1–10 mM) and indirectly by
energy depletion (>10 mM) [98]. In addition, we showed that incubation of isolated rat skeletal
muscles with sodium salicylate (>5 mM) increased AMPKα Thr172 phosphorylation and AMPK
activity accompanied by the reduction of energy status (ATP, PCr, and glycogen) [97]. The
depletion of energy levels in response to sodium salicylate stimulation was also observed in
Drosophila tissue culture (SL2) cells [99] and neutrophils [100]. Inhibition of oxidative
phosphorylation by sodium salicylate was suggested to cause to energy depletion [101]. These
findings suggest that salicylate stimulates AMPK via both energy-dependent and energy-
independent processes in skeletal muscle. It seems that CaMKK signaling is not involved in
salicylate-induced AMPK activation because the CaMKK inhibitor STO-609 had no effect on
responses to salicylate [98].
3.5. p-Coumaric acid
p-Coumaric acid (4-hydroxycinnamic acid) is the precursor of caffeic acid and has potential to
reduce the risk of T2DM. Some studies showed that chronic (30–45 days) treatment with p-
coumaric acid improved fasting blood glucose and HbA1c levels in STZ-induced diabetic rats
[102–104]. In addition, a study demonstrated that p-coumaric acid stimulated insulin-inde-
pendent glucose transport and AMPKα Thr172 phosphorylation in L6 skeletal muscle cells and
that the upregulation of glucose transport was partially attenuated by concomitant treatment
with AMPK inhibitor compound C [105]. This finding indicates that p-coumaric acid stimulates
insulin-independent glucose transport via AMPK-activation in skeletal muscle.
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3.6. Ferulic acid
Ferulic acid (4-hydroxy-3-methoxycinnamic acid) is derived from the biosynthesis of caffeic
acid and has antidiabetic effects. Chronic treatment with ferulic acid showed a hypoglycemic
effect in diabetic mice [106–108]. A study reported that ferulic acid stimulated insulin-
independent glucose transport in L6 skeletal muscle cells in a dose-dependent (<50 μM) and
time-dependent (<5 h) manners [63]. In contrast, another study showed that treatment with
ferulic acid (250–500 μM) inhibited insulin-independent glucose transport in L6 skeletal
muscle cells [109]. Therefore, further studies are needed to clear the effect of ferulic acid on
glucose transport system.
3.7. Sinapic acid
Sinapic acid (sinapinic acid or 4-hydroxy-3,5-dimethoxycinnamic acid) is known to have an
anti-inflammatory action through NF-κB inactivation [110]. Inflammation links with the
progress of T2DM, and thus, it is indicated the merit of sinapic acid in the treatment of T2DM.
Indeed, a single administration of sinapic acid (10–30 mg/kg) dose-dependently reduced the
hyperglycemia of STZ-induced diabetic rats [111, 112]. Further, sinapic acid (0.1–10 μM)
stimulated enhanced insulin-independent glucose transport in isolated rat skeletal muscle and
L6 skeletal muscle cells [112]. Repeated treatment with sinapic acid (25 mg/kg) for 3 days
increased the gene expression of GLUT4 in skeletal muscle of STZ-induced diabetic rats [112].
Considering that AMPK promotes GLUT4 expression [66–68], sinapic acid-induced stimula-
tion of glucose transport and GLUT4 expression may be mediated by AMPK activation.
4. Conclusion
Phytomedicine is becoming to be an important medical treatment, and thus it is necessary to
understand the molecular mechanism underlying the effectiveness of phytochemicals on
health promotion. In this chapter, we reviewed the relationship between phenolic acids and
T2DM focusing on skeletal muscle glucose transport systems. Among many phenolic acids, it
has been reported that caffeic acid, chlorogenic acid, gallic acid, salicylic acid, p-coumaric acid,
and sinapic acid stimulate glucose transport in skeletal muscle (Table 1). AMPK appears to be
involved in these glucose utilization processes. Caffeic acid, chlorogenic acid, salicylic acid,
and p-coumaric acid seem to have capacity for stimulating AMPK activity, thereby enhancing
insulin-independent glucose transport. On the other hand, gallic acid has no effect on AMPK
activity but stimulates insulin signaling without insulin. Caffeic acid and salicylic acid may
also enhance insulin sensitivity by suppressing IKK/NF-κB signaling.
Physical exercise is a powerful tool that promotes good health, and it reduces the risk of T2DM.
Skeletal muscle AMPK is considered to be a candidate therapeutic target molecule in T2DM
since AMPK is activated by physical exercise. If skeletal muscle AMPK could be activated by
alternative approaches including phytochemicals, it would benefit people who are unable to
engage in physical exercise. As described above, caffeic acid has no capacity for enhancing
contraction-induced AMPK activity. This finding suggests that caffeic acid may not strengthen
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the exercise benefit but simultaneously means that caffeic acid and contraction have a common
mechanism to stimulating insulin-independent glucose transport through AMPK. Therefore,
caffeic acid has a potential as an exercise-mimetic stimulator for glucose transport systems.
Thus, we expect that some kinds of phytochemicals have potential to act as preventive and
therapeutic agents for T2DM.
Phenolic acids Insulin-dependent
glucose transport
Insulin-
independent
glucose transport
Molecular responses
Caffeic acid ↑ (insulin resistance
state)
↑ AMPK activity ↑, Energy status ↓, NF-κB activity ↓
Chlorogenic acid — ↑ AMPK activity ↑ (>1 mM, >60 min)
AMPK expression ↑, CaMKK expression ↑
Gallic acid — ↑ Akt activity ↑, AMPK activity →
Salicylic acid ↑ (lipid infused
state) 
↑ Insulin-stimulated IRS-1 tyrosine phosphorylation ↑,
Insulin-stimulated PI3K activity ↑
NF-κB activity ↓, AMPK activity ↑
Energy status ↓, CaMKK activity →
p-Coumaric acid  — ↑ AMPK activity ↑
Ferulic acid — ↑ —
Synapic acid — ↑ GLUT4 gene expression ↑
AMPK, 5′AMP-activated protein kinase; CaMKK, Ca2+/calmodulin-dependent protein kinase kinase; GLUT4, glucose
transporter 4; IRS-1, insulin receptor substrate 1; NF-κB, nuclear factor-κB; PI3K, phosphatydilinositol-3 kinase; ↑,
increase; ↓, decrease; →, no change; —, no study.
Table 1. Summary of the effect of phenolic acids on skeletal muscle glucose transport.
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